The comorbidity of HIV-associated neurocognitive disorders and Alzheimer's disease: a foreseeable medical challenge in post-HAART era
about
Natural Products as Anti-HIV Agents and Role in HIV-Associated Neurocognitive Disorders (HAND): A Brief OverviewRole of HIV in amyloid metabolismChronic inflammation and the role for cofactors (hepatitis C, drug abuse, antiretroviral drug toxicity, aging) in HAND persistenceβ-Amyloid1-42, HIV-1Ba-L (clade B) infection and drugs of abuse induced degeneration in human neuronal cells and protective effects of ashwagandha (Withania somnifera) and its constituent Withanolide ARNA deep sequencing analysis reveals that nicotine restores impaired gene expression by viral proteins in the brains of HIV-1 transgenic ratsHIV-1 stimulates nuclear entry of amyloid beta via dynamin dependent EEA1 and TGF-β/Smad signaling.Antiretroviral penetration into the CNS and incidence of AIDS-defining neurologic conditionsCaffeine Blocks HIV-1 Tat-Induced Amyloid Beta Production and Tau Phosphorylation.Neurocognitive consequences of HIV infection in older adults: an evaluation of the "cortical" hypothesisTranscriptional profile of HIV-induced nuclear translocation of amyloid β in brain endothelial cells.Neurodegenerative effects of recombinant HIV-1 Tat(1-86) are associated with inhibition of microtubule formation and oxidative stress-related reductions in microtubule-associated protein-2(a,b)The effect of HIV protease inhibitors on amyloid-β peptide degradation and synthesis in human cells and Alzheimer's disease animal modelEditorial neuroAIDS review.Lipid rafts and functional caveolae regulate HIV-induced amyloid beta accumulation in brain endothelial cells.Mitochondrial Haplogroup Influences Motor Function in Long-Term HIV-1-Infected IndividualsKetone bodies protection against HIV-1 Tat-induced neurotoxicity.Interacting partners of macrophage-secreted cathepsin B contribute to HIV-induced neuronal apoptosis.11C-PiB imaging of human immunodeficiency virus-associated neurocognitive disorderCurrent understanding of HIV-associated neurocognitive disorders pathogenesis.Endolysosome involvement in HIV-1 transactivator protein-induced neuronal amyloid beta production.Amyloid beta accumulation in HIV-1-infected brain: The role of the blood brain barrierPivotal Role of Receptor-Interacting Protein Kinase 1 and Mixed Lineage Kinase Domain-Like in Neuronal Cell Death Induced by the Human Neuroinvasive Coronavirus OC43.Antiretroviral drugs induce oxidative stress and neuronal damage in the central nervous systemInfectious agents and neurodegeneration.Antiretroviral medications disrupt microglial phagocytosis of β-amyloid and increase its production by neurons: implications for HIV-associated neurocognitive disorders.Janus-faced microglia: beneficial and detrimental consequences of microglial phagocytosis.Type I Interferon at the Interface of Antiviral Immunity and Immune Regulation: The Curious Case of HIV-1.Role of nuclear medicine in neuroHIV: PET, SPECT, and beyond.Differentiating HIV-Associated Neurocognitive Disorders From Alzheimer's Disease: an Emerging Issue in Geriatric NeuroHIV.Cerebrospinal fluid biomarkers and HIV-associated neurocognitive disorders in HIV-infected individuals in Rakai, Uganda.HIV-associated dementia in older adults: clinical and tomographic aspects.HIV-1-induced amyloid beta accumulation in brain endothelial cells is attenuated by simvastatinEffect of coadministration of neurovite and Lamivudine on the histomorphology of the cerebellum of wistar rats.Extracellular vesicles of the blood-brain barrier: Role in the HIV-1 associated amyloid beta pathology.HIV Protease Inhibitors Alter Amyloid Precursor Protein Processing via β-Site Amyloid Precursor Protein Cleaving Enzyme-1 Translational Up-Regulation.Soluble TLR2 and 4 concentrations in cerebrospinal fluid in HIV/SIV-related neuropathological conditions.HIV-1 protein-mediated amyloidogenesis in rat hippocampal cell cultures.Verbal list learning and memory profiles in HIV-infected adults, Alzheimer's disease, and Parkinson's disease: An evaluation of the "cortical hypothesis" of NeuroAIDS.HIV-1 reduces Abeta-degrading enzymatic activities in primary human mononuclear phagocytesBrain viral burden, neuroinflammation and neurodegeneration in HAART-treated HIV positive injecting drug users.
P2860
Q26770401-E3D58EB6-2D87-4C2A-871A-D859048839C6Q26824179-A7EEFFAA-FA9F-45E8-9E00-944179E3423AQ26825762-B97E3398-5204-4C1D-8C11-3E29B8C78D43Q28545117-74959AD3-6A7B-4D58-88AE-A4F807C6DDEFQ30418181-3ED5BAA8-AAA6-423E-8D13-AC49B61B6FE2Q33604503-6410E83B-1E94-4FED-9CD6-B489B99DF048Q33980117-DDE90C78-236C-4902-B17E-C63455D68583Q34540333-2078264B-11B2-4A4F-90FE-31CBE01CDDDDQ35032667-21FDA18C-D23D-4A1B-BEAA-19E25D98144AQ35072502-34AD3394-B8DF-48DB-8F3F-196B66301902Q35131200-7774CF79-D599-4265-9586-AE8AFF499CA6Q35570991-C243B827-9F2A-4F2A-A863-8FB43B184F55Q35731648-2A33E9FE-8851-4C4A-AC57-D360F3273194Q35947300-59B87EB0-9516-4D09-8E4F-457542B20FF0Q36155099-919E9A90-DA1F-434B-9983-3509145C895CQ36166231-50A6AB44-3459-48F8-8BB6-C1EB27B49EE4Q36259524-C573DFB5-2647-42BC-A316-6247FDF87EF8Q36507182-FF84D8D3-D983-46F3-B7D4-5A37FEEAAEF5Q36932005-ADA83FE9-970F-4FCC-9C3D-1C428E3EC252Q36997333-58B8C726-2642-4C41-BE06-933A0EF6D977Q37243920-47D746A4-2A1D-4BC4-AEAB-DE1519805B9DQ37512895-C5772A53-645C-4FA2-8F9B-63EB8FEBE6A3Q37592018-C7D385AE-D31F-4705-A48B-377066481099Q37848266-A639A413-674E-46E1-BA26-6BC074A57753Q37886067-0B79616B-3F05-4829-9C7E-0907D3EAA196Q38079579-19912B64-A378-4901-91EB-9D2A48ABAD44Q38181142-27CBF118-CC91-44D4-ADCE-C752D1F17311Q38208168-3CC0C5EE-441C-4CAA-AB06-0ED644354A68Q38639562-E3B20AEF-67B1-4AE0-BAEB-E4C90E039A8EQ38851823-55AE2ADC-3456-4155-9E71-5519CA34F14BQ38921611-60EBD07C-5A89-44FE-88ED-2115407252C9Q39769825-5185B094-1C45-4EF9-B926-C85FCC4851BFQ40309706-5A3A8346-C27B-45A1-989E-D6202F693E2AQ40389352-E19E668D-1325-4C63-9ADC-868B77C54779Q40404098-AEA57939-13FD-4402-AF68-9024A6D5985CQ40437527-69FC57B8-C71B-4110-9332-EFA654F5DD5EQ40701277-C9E31578-8703-45CB-A5A4-5C92B94B7BE4Q40705620-40EC49CF-C442-4ABD-A65F-2B0FCD8894EEQ42130528-391B456C-87A8-4AE2-A084-896CBFE4BDB3Q42243533-2212F55F-E7B9-47E0-83A1-40280C746CD5
P2860
The comorbidity of HIV-associated neurocognitive disorders and Alzheimer's disease: a foreseeable medical challenge in post-HAART era
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
The comorbidity of HIV-associa ...... al challenge in post-HAART era
@en
The comorbidity of HIV-associa ...... l challenge in post-HAART era.
@nl
type
label
The comorbidity of HIV-associa ...... al challenge in post-HAART era
@en
The comorbidity of HIV-associa ...... l challenge in post-HAART era.
@nl
prefLabel
The comorbidity of HIV-associa ...... al challenge in post-HAART era
@en
The comorbidity of HIV-associa ...... l challenge in post-HAART era.
@nl
P2860
P1476
The comorbidity of HIV-associa ...... al challenge in post-HAART era
@en
P2093
Tsuneya Ikezu
P2860
P2888
P304
P356
10.1007/S11481-008-9136-0
P577
2008-11-19T00:00:00Z